Abstract
Background
The object of this study is to clarify the association of an angiogenic factor, PD-ECGF (platelet-derived endothelial cell growth factor/thymidine phosphorylase), with clinicopathologic factors, in this case tumor angiogenesis, in epithelial ovarian cancers.
Methods
Tumor specimens were obtained at the time of surgery from the primary lesion in 60 patients with epithelial ovarian cancer. Histologic cell types were assigned to tumors according to the World Health Organization classification: 26 were classified as serous adenocarcinoma, 15 as endometrioid adenocarcinoma, 9 as mucinous adenocarcinoma, 9 as clear cell carcinoma, and 1 as undifferentiated carcinoma. Surgical staging was based on the international Federation of Gynecology and Obstetrics (FIGO) staging system: 16 were stage I, 6 were stage II, 34 were stage III, and 4 were stage IV. Expression of PD-ECGF was evaluated by immunohistochemical staining. Microvessel density was assessed by immunostaining for factor VIII-related antigen in the most neovascularized area.
Results
Stroma cells stained more strongly than cancer cells (80% vs. 33%). The immunopositivity of PD-ECGF in stroma cells was higher in cases of advanced cancer. Expression of PD-ECGF in mucinous adenocarcinomas was significantly higher than that in serous adenocarcinomas, while PD-ECGF expression in clear cell carcinomas was significantly lower. The microvessel density in the cases with marked PD-ECGF-positive stroma cells was significantly higher than that in the cases with absent/minimal PD-ECGF-positive stroma cells (P<0.05).
Conclusion
The expression of PD-ECGF may play a crucial role in the promotion of angiogenesis in epithelial ovarian cancers.
Similar content being viewed by others
References
Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267: 10931–10934.
Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 1990;82:4–6.
Liotta L, Kleinerman J, Saldel G. Quantitative relationships of intravascular tumor cells, tumor vessel, and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997–1004.
Folkman J, Klagsburn M. Angiogenic factors. Science 1987;235:442–447.
Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1–8.
Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79:185–188.
Kuwano M, Ushiro S, Ryuto M, Samoto H, Izumi H, Ito K, Abe T, Nakamura M, Ono M, Kohno K. Regulation of angiogenesis by growth factors. Gann Monogr Cancer Res 1994;42:113–125.
Ishikawa F, Miyazono K, Hellman U, Hannes D, Wernstadt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial growth factor. Nature 1989;338:557–562.
Nakanishi Y, Kodama J, Yoshinouchi M, Tokumo K, Kamimura S, Okuda H, Kudo T. The expression of vascular endothelial growth factor and transforming growth factor-β associates with angiogenesis in epithelial ovarian cancer. Int J Gynecol Pathol 1997;16:256–262.
Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama S, Fukui K, Ishizawa M, Yamada Y. Nature 1992; 356:668.
Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishizawa M, Yamada Y, Akiyama S. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem 1993;114:9–14.
Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S, Yamada Y. Angiogenic activity of enzymes. Nature 1994;368:198.
Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y, Akiyama S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 1995;55:1687–1690.
Cannistra SA. Cancer of the ovary. N Engl J Med 1993; 329:1550–1559.
Kodama J, Hayase R, Okuda H, Yoshinouchi M, Kudo T. Reverse correlation between P-glycoprotein expression and proliferative activity in endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol 1995;59:45–51.
Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bicknell R. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 1994;86:1234–1238.
Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyana S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes, and tumors. Biochim Biophys Acta 1990;1034:107–113.
Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265–270.
Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T. The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett 1995;92:1–5.
Author information
Authors and Affiliations
About this article
Cite this article
Nakanishi, Y., Kodama, J., Tokumo, K. et al. The expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase associates with angiogenesis in epithelial ovarian cancer. Int J Clin Oncol 2, 219–223 (1997). https://doi.org/10.1007/BF02488995
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02488995